ZEJULA is a poly(ADP-ribose) polymerase (PARP) inhibitor indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
Niraparib is indicated for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
In October 2019, the indication for niraparib was expanded to include people with advanced ovarian, fallopian tube, or primary peritoneal cancer treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency (HRD)-positive status.
In April 2020, the indication for niraparib was expanded to include the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
In the European Union, niraparib is indicated: as monotherapy for the maintenance treatment of adults with advanced epithelial (FIGO Stages III and IV) high-grade ovarian, fallopian tube or primary peritoneal cancer.
Please contact at +91 9910645395 or send your enquiry at info@cancermedicinesnetwork to find the price of ZEJULA (niraparib) capsules, for oral use in Vietnam, Philippines and Ireland. We take guarantee of quality and delivery as per the buyer’s requirements.
To buy ZEJULA (niraparib) capsules in India, request you to send your details via query form or you can call or WhatsApp (+91) 9910645395 or send mail to urgent@cancermedicinesnetwork.com to know the best price. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Yes, Verve Biosciences can assist in the delivery of ZEJULA (niraparib) capsules, doctor prescribed medicine. The Order Will Be Confirmed Only After The Receipt Of Valid prescription of Doctor and Import permit if applicable.
Verve Biosciences have exported ZEJULA (niraparib) capsules in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.